MedPath

Diabetic Retinopathy Screening in General Practice

Completed
Conditions
Diabetic Retinopathy
Type2 Diabetes
Interventions
Diagnostic Test: Diabetic Retinopathy Screening
Registration Number
NCT05276778
Lead Sponsor
Aalborg University
Brief Summary

Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.

The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Diagnosed with type 2 diabetes
  • Understands Danish
  • Age between 18-70
Exclusion Criteria
  • Blindness
  • Cannot partake in second screening

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
People with type 2 diabetesDiabetic Retinopathy ScreeningPeople diagnosed with type 2 diabetes age 18-70
Primary Outcome Measures
NameTimeMethod
Patients' acceptance of diabetic retinopathy screenings in general practice1 day (the questionnarie is fufilled one time after the retinopaty screening in general practice)

Questionnaire

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Malene Krogh

🇩🇰

Aalborg, DK, Denmark

© Copyright 2025. All Rights Reserved by MedPath